Skip to main navigation
About
About
Contact Us
Pipeline
Pipeline
DKN-01 programs
Gastric Cancer
Colorectal Cancer
Endometrial Cancer
Prostate Cancer
Lung Cancer
Anti-CLDN18.2 programs
FL-301 (NBL-015)
FL-302 (NBL-016)
FL-501
Science
Science
DKK1
DKN-01
Claudin18.2
GDF15
Patients
Patients
Expanded Access
Careers
Investors
Investors
Stock Information
News Releases
Presentations & Events
Financial Information
Corporate Governance
Information Request
Event
Details
Leap Therapeutics Acquires Flame Biosciences
Jan 17, 2023 at 9:00 AM EST
Listen to webcast
Print Page
Email Alerts
Contact Us
